Melinda Decker
Former Head of Oncology and Immuno-Oncology, Digit
AstraZeneca

Melinda Decker is a passionate leader with a rare mix of both commercial and R&D expertise, developed over nearly 20 years in the pharmaceutical-biotech industry. She has broad therapeutic experience with biologic, small molecule and digital health products, across both specialty and primary care, and with both global and local markets. She currently is the Oncology TA Head for Intelligent Pharmaceuticals, AstraZeneca’s digital therapeutics team, focused on improving patient outcomes through digital health. In this role, she works to integrate medicines with technology such as connected devices, sensors, and smart packaging across the entire development cycle of launched, pre-launched and pipeline products. She holds an MS in Biochemical Engineering and an MBA in Finance and Marketing.